These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

529 related items for PubMed ID: 15693793

  • 1. CD226 is expressed on the megakaryocytic lineage from hematopoietic stem cells/progenitor cells and involved in its polyploidization.
    Ma D, Sun Y, Lin D, Wang H, Dai B, Zhang X, Ouyang W, Jian J, Jia W, Xu X, Jin B.
    Eur J Haematol; 2005 Mar; 74(3):228-40. PubMed ID: 15693793
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Changes in cyclin expression during proliferation and differentiation of CD34(+) cells derived from fetal liver induced by thrombopoietin].
    Ma DC, Jin BQ, Sun YH, Chang KZ, Dai B, Chu JJ, Liu YG.
    Sheng Li Xue Bao; 2001 Aug; 53(4):296-302. PubMed ID: 11930209
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Enforced TAL-1 expression stimulates primitive, erythroid and megakaryocytic progenitors but blocks the granulopoietic differentiation program.
    Valtieri M, Tocci A, Gabbianelli M, Luchetti L, Masella B, Vitelli L, Botta R, Testa U, Condorelli GL, Peschle C.
    Cancer Res; 1998 Feb 01; 58(3):562-9. PubMed ID: 9458106
    [Abstract] [Full Text] [Related]

  • 6. Apoptosis of erythroid precursors under stimulation with thrombopoietin: contribution to megakaryocytic lineage choice.
    Sawai N, Koike K, Ito S, Kurokawa Y, Mwamtemi HH, Kinoshita T, Sakashita K, Higuchi T, Takeuchi K, Shiohara M, Ogami K, Komiyama A.
    Stem Cells; 1999 Feb 01; 17(1):45-53. PubMed ID: 10215401
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Thrombopoietin combined with early-acting growth factors effectively expands human hematopoietic progenitor cells in vitro.
    Hunnestad JA, Steen R, Tjønnfjord GE, Egeland T.
    Stem Cells; 1999 Feb 01; 17(1):31-8. PubMed ID: 10215399
    [Abstract] [Full Text] [Related]

  • 9. Decrease in apoptosis and increase in polyploidization of megakaryocytes by stem cell factor during ex vivo expansion of human cord blood CD34+ cells using thrombopoietin.
    Kie JH, Yang WI, Lee MK, Kwon TJ, Min YH, Kim HO, Ahn HS, Im SA, Kim HL, Park HY, Ryu KH, Chung WS, Shin MH, Jung YJ, Woo SY, Park HK, Seoh JY.
    Stem Cells; 2002 Feb 01; 20(1):73-9. PubMed ID: 11796924
    [Abstract] [Full Text] [Related]

  • 10. Downregulation of signal transducer and activator of transcription 5 (STAT5) in CD34+ cells promotes megakaryocytic development, whereas activation of STAT5 drives erythropoiesis.
    Olthof SG, Fatrai S, Drayer AL, Tyl MR, Vellenga E, Schuringa JJ.
    Stem Cells; 2008 Jul 01; 26(7):1732-42. PubMed ID: 18436865
    [Abstract] [Full Text] [Related]

  • 11. Differential gene expression in human hematopoietic stem cells specified toward erythroid, megakaryocytic, and granulocytic lineage.
    Liu XL, Yuan JY, Zhang JW, Zhang XH, Wang RX.
    J Leukoc Biol; 2007 Oct 01; 82(4):986-1002. PubMed ID: 17626799
    [Abstract] [Full Text] [Related]

  • 12. Insights into the cellular mechanisms of erythropoietin-thrombopoietin synergy.
    Papayannopoulou T, Brice M, Farrer D, Kaushansky K.
    Exp Hematol; 1996 Apr 01; 24(5):660-9. PubMed ID: 8605971
    [Abstract] [Full Text] [Related]

  • 13. Special Education.
    Kozutsumi H.
    Oncologist; 1996 Apr 01; 1(1 & 2):116-118. PubMed ID: 10387976
    [Abstract] [Full Text] [Related]

  • 14. Gene Ontology-driven transcriptional analysis of CD34+ cell-initiated megakaryocytic cultures identifies new transcriptional regulators of megakaryopoiesis.
    Fuhrken PG, Chen C, Apostolidis PA, Wang M, Miller WM, Papoutsakis ET.
    Physiol Genomics; 2008 Apr 22; 33(2):159-69. PubMed ID: 18252802
    [Abstract] [Full Text] [Related]

  • 15. Timing and expression level of protein kinase C epsilon regulate the megakaryocytic differentiation of human CD34 cells.
    Gobbi G, Mirandola P, Sponzilli I, Micheloni C, Malinverno C, Cocco L, Vitale M.
    Stem Cells; 2007 Sep 22; 25(9):2322-9. PubMed ID: 17569788
    [Abstract] [Full Text] [Related]

  • 16. Differentiation of hematopoietic progenitor cells towards the myeloid and B-lymphoid lineage by hepatocyte growth factor (HGF) and thrombopoietin (TPO) together with early acting cytokines.
    Grassinger J, Mueller G, Zaiss M, Kunz-Schughart LA, Andreesen R, Hennemann B.
    Eur J Haematol; 2006 Aug 22; 77(2):134-44. PubMed ID: 16856909
    [Abstract] [Full Text] [Related]

  • 17. Transcriptional profiling of human hematopoiesis during in vitro lineage-specific differentiation.
    Komor M, Güller S, Baldus CD, de Vos S, Hoelzer D, Ottmann OG, Hofmann WK.
    Stem Cells; 2005 Sep 22; 23(8):1154-69. PubMed ID: 15955831
    [Abstract] [Full Text] [Related]

  • 18. Proliferative and differentiative potential of thrombopoietin-responsive precursors: expression of megakaryocytic and erythroid lineages.
    Higuchi T, Koike K, Sawai N, Koike T.
    Exp Hematol; 1997 Jun 22; 25(6):463-70. PubMed ID: 9197322
    [Abstract] [Full Text] [Related]

  • 19. Do the preclinical effects of thrombopoietin correlate with its in vitro properties?
    Kaushansky K, Broudy VC, Sitnicka E, Lofton-Day C, Grossmann A, Sprugel K.
    Stem Cells; 1996 Jun 22; 14 Suppl 1():108-11. PubMed ID: 11012209
    [Abstract] [Full Text] [Related]

  • 20. Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture.
    Mattia G, Milazzo L, Vulcano F, Pascuccio M, Macioce G, Hassan HJ, Giampaolo A.
    Exp Hematol; 2008 Feb 22; 36(2):244-52. PubMed ID: 18023520
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.